Illumina Inc ILMN:NASDAQ

Last Price$273.37Cboe Real-Time Last Sale as of 1:38PM ET 2/25/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-7.75(2.76%)
Bid (Size)$273.32 (100)
Ask (Size)$273.50 (92)
Day Low / High$273.12 - 282.65
Volume647.6 K
 

View Biotechnology IndustryPeer Comparison as of 02/25/2020

 

Illumina Inc ( NASDAQ )

Price: $273.37
Change: -7.75 (2.76%)
Volume: 647.6 K
1:38PM ET 2/25/2020
 
 

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $449.41
Change: +24.03 (5.65%)
Volume: 2.4 M
1:39PM ET 2/25/2020
 
 

Biogen Inc ( NASDAQ )

Price: $326.73
Change: +0.75 (0.23%)
Volume: 972.5 K
1:39PM ET 2/25/2020
 
 

Agilent Technologies Inc ( NYSE )

Price: $78.91
Change: -1.59 (1.98%)
Volume: 1.4 M
1:38PM ET 2/25/2020
 
 

Alexion Pharmaceuticals Inc ( NASDAQ )

Price: $95.92
Change: -3.10 (3.13%)
Volume: 2.0 M
1:38PM ET 2/25/2020
 

Read more news Recent News

Insider Trends: 90-Day Insider Buying Trend Reduced with Disposition of Illumina Shares
5:08PM ET 2/20/2020 MT Newswires

Omead Ostadan, SVP Mktg, Prod & Strat Plan, reported a sale of 1,800 shares in Illumina (ILMN) on Feb 18, 2020, for $537,959. Following the Form 4 filing...

Insider Trends: Insider at Illumina Gets Share Award, Exercises Derivative Security, Makes Tax Sale with Portion
10:17PM ET 2/13/2020 MT Newswires

On Feb 11, 2020, Susan H Tousi, SVP Product Development, was awarded 4,985 Illumina (ILMN) shares and exercised options/derivative securities for 9,969...

Insider Trends: Illumina Insider Gets Share Award, Exercises Derivative Security, Sells Portion for Taxes
10:17PM ET 2/13/2020 MT Newswires

Omead Ostadan, SVP Mktg, Prod & Strat Plan on Feb 11, 2020, was awarded 6,744 Illumina (ILMN) shares and exercised options/derivative securities for 13,488...

Insider Trends: Illumina Insider Awarded Shares, Exercises Derivative Security, Pays Taxes with Portion
10:17PM ET 2/13/2020 MT Newswires

On Feb 11, 2020, Mark Van Oene, SVP Chief Commercial Officer, was awarded 5,821 Illumina (ILMN) shares and exercised options/derivative securities for...

View all Commentary and Analysis

Illumina: Reasons To Be Bullish
4:31PM ET 2/05/2020 Seeking Alpha

Illumina, Inc. 2019 Q4 - Results - Earnings Call Presentation
11:48AM ET 1/30/2020 Seeking Alpha

IBB: The Stage Is Set For Next Bull Market In Biotechs
11:22AM ET 1/30/2020 Seeking Alpha

Illumina: Strongly Positioned But That Merger Blow Has Raised Questions
9:41AM ET 1/30/2020 Seeking Alpha

Company Profile

Business DescriptionIllumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA. View company web site for more details
Address5200 Illumina Way
San Diego, California 92122
Phone+1.858.202.4500
Number of Employees7,300
Recent SEC Filing02/20/20204
President, Chief Executive Officer & DirectorFrancis A. deSouza
Senior Vice President-Global Quality & OperationsRobert P. Ragusa
Chief Financial Officer & Senior Vice PresidentSam A. Samad
Chief Technology Officer & Senior Vice PresidentMostafa Ronaghi

Company Highlights

Price Open$282.65
Previous Close$281.12
52 Week Range$263.30 - 380.76
Market Capitalization$40.2 B
Shares Outstanding147.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement04/23/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings45.18
Earnings per Share$4.18
Beta vs. S&P 500N/A
Revenue$3.3 B
Net Profit Margin28.98%
Return on Equity24.27%

Analyst Ratings as of 02/21/2020

Buy
11
Overweight
2
Hold
5
Underweight
1
Sell
1
Consensus RecommendationConsensus Icon
Powered by Factset